276 related articles for article (PubMed ID: 35069833)
1. Cardiovascular comorbidities in psoriasis (Review).
Branisteanu DE; Nicolescu AC; Branisteanu DC; Branisteanu CI; Dragoi AC; Bogdanici CM; Toader MP; Tucaliuc AL; Dimitriu A; Daogaru D; Pirvulescu RA; Porumb EA
Exp Ther Med; 2022 Feb; 23(2):152. PubMed ID: 35069833
[TBL] [Abstract][Full Text] [Related]
2. Pathogenesis of Chronic Plaque Psoriasis and Its Intersection With Cardio-Metabolic Comorbidities.
Gisondi P; Bellinato F; Girolomoni G; Albanesi C
Front Pharmacol; 2020; 11():117. PubMed ID: 32161545
[TBL] [Abstract][Full Text] [Related]
3. Management of psoriasis as a systemic disease: what is the evidence?
Korman NJ
Br J Dermatol; 2020 Apr; 182(4):840-848. PubMed ID: 31225638
[TBL] [Abstract][Full Text] [Related]
4. Cardiometabolic Comorbidities in Patients With Psoriasis: Focusing on Risk, Biological Therapy, and Pathogenesis.
Cai J; Cui L; Wang Y; Li Y; Zhang X; Shi Y
Front Pharmacol; 2021; 12():774808. PubMed ID: 34803716
[TBL] [Abstract][Full Text] [Related]
5. Psoriasis and Cardiovascular Diseases: An Immune-Mediated Cross Talk?
Orlando G; Molon B; Viola A; Alaibac M; Angioni R; Piaserico S
Front Immunol; 2022; 13():868277. PubMed ID: 35686132
[TBL] [Abstract][Full Text] [Related]
6. Inflammation in atherosclerosis and psoriasis: common pathogenic mechanisms and the potential for an integrated treatment approach.
Späh F
Br J Dermatol; 2008 Aug; 159 Suppl 2():10-7. PubMed ID: 18700910
[TBL] [Abstract][Full Text] [Related]
7. Psoriasis a Cause of Cardiovascular Diseases: A Review Article.
Gupta A; Madke B
Cureus; 2022 Aug; 14(8):e27767. PubMed ID: 36106203
[TBL] [Abstract][Full Text] [Related]
8. Biologics for the primary care physician: Review and treatment of psoriasis.
Schadler ED; Ortel B; Mehlis SL
Dis Mon; 2019 Mar; 65(3):51-90. PubMed ID: 30037762
[TBL] [Abstract][Full Text] [Related]
9. Cutaneous and Systemic Psoriasis: Classifications and Classification for the Distinction.
Yan BX; Chen XY; Ye LR; Chen JQ; Zheng M; Man XY
Front Med (Lausanne); 2021; 8():649408. PubMed ID: 34722555
[TBL] [Abstract][Full Text] [Related]
10. Cytokine alterations in psoriasis: an updated review.
Seyedmirzaei H; Rezaei N
Expert Rev Clin Immunol; 2021 Dec; 17(12):1323-1335. PubMed ID: 34845948
[TBL] [Abstract][Full Text] [Related]
11. The Impact of Treatment with IL-17/IL-23 Inhibitors on Subclinical Atherosclerosis in Patients with Plaque Psoriasis and/or Psoriatic Arthritis: A Systematic Review.
Tsiogka A; Gregoriou S; Stratigos A; Soulaidopoulos S; Rompoti N; Panagakis P; Papoutsaki M; Kostakis P; Kontochristopoulos G; Tsioufis K; Campanati A; Offidani A; Vlachopoulos C; Rigopoulos D
Biomedicines; 2023 Jan; 11(2):. PubMed ID: 36830855
[TBL] [Abstract][Full Text] [Related]
12. Psoriasis: Recognition and Management Strategies.
Garner KK; Hoy KDS; Carpenter AM
Am Fam Physician; 2023 Dec; 108(6):562-573. PubMed ID: 38215417
[TBL] [Abstract][Full Text] [Related]
13. Psoriasis and Molecular Target Therapies: Evidence of Efficacy in Preventing Cardiovascular Comorbidities.
Potestio L; Tommasino N; Lauletta G; Martora F; Megna M
Dermatol Ther (Heidelb); 2024 Apr; 14(4):841-852. PubMed ID: 38592640
[TBL] [Abstract][Full Text] [Related]
14. Investigating the Link between Psoriasis and Cardiovascular Disease: Current Evidence, Therapeutic Implications and Perspectives.
Kapniari E; Papadimitriou P; Dalamaga M; Makavos G; Piaserico S; Egeberg A; Ikonomidis I; Papadavid E
Curr Vasc Pharmacol; 2020; 18(6):592-609. PubMed ID: 32445456
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and Safety of Biologics for Psoriasis and Psoriatic Arthritis and Their Impact on Comorbidities: A Literature Review.
Kamata M; Tada Y
Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32121574
[TBL] [Abstract][Full Text] [Related]
16. Novel anti-inflammatory therapies to reduce cardiovascular burden of psoriasis.
Piros ÉA; Szilveszter B; Vattay B; Maurovich-Horvat P; Szalai K; Dósa E; Merkely B; Holló P
Dermatol Ther; 2021 Jan; 34(1):e14721. PubMed ID: 33373079
[TBL] [Abstract][Full Text] [Related]
17. Metabolic comorbidities and psoriasis.
Gisondi P; Ferrazzi A; Girolomoni G
Acta Dermatovenerol Croat; 2010; 18(4):297-304. PubMed ID: 21251450
[TBL] [Abstract][Full Text] [Related]
18. Catastrophic stroke burden in a patient with uncontrolled psoriasis and psoriatic arthritis: a case report.
Fan JM; Solomon DA; López GY; Hofmann JW; Colorado RA; Kim AS; Meisel K; Halabi C
BMC Neurol; 2020 Mar; 20(1):106. PubMed ID: 32199449
[TBL] [Abstract][Full Text] [Related]
19. Cardiometabolic Comorbidities in Psoriasis and Psoriatic Arthritis.
Puig L
Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29295598
[TBL] [Abstract][Full Text] [Related]
20. [Psoriasis and cardiovascular disease].
Torres T; Sales R; Vasconcelos C; Selores M
Acta Med Port; 2013; 26(5):601-7. PubMed ID: 24192101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
